RENK signs development contract with leading European systems house for land forces Villepinte / Frankreich, 20. Juni 2024 – RENK, a leading provider of vehicle mobility solutions, is pleased to announce the signing of a development contract with one of the leading European systems houses for land ...
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
STADA reduces carbon emissions and increases its renewable energy supply on sustainability journey - Total carbon emissions by STADA reduced by 25% between 2020 and 2023 - Around 45% of STADA’s electricity consumption now comes from renewable ...
DHL Group startet solide in das Jahr 2024 - Konzernumsatz im ersten Quartal 2024 mit EUR 20,3 Milliarden Euro nahezu stabil (Q1 2023: 20,9 Milliarden Euro) - Operatives Ergebnis (EBIT) mit 1,3 Milliarden Euro wie erwartet unter Vorjahresniveau (Q1 2023: 1,6 Milliarden Euro), aber über ...
Leipzig Tourismus und Marketing GmbH
Leipzig Tourismus und Marketing GmbH
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
